Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor
Author:
Funder
JSPS KAKENHI
Publisher
Elsevier BV
Subject
Virology,Pharmacology
Reference31 articles.
1. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections;Balfour;J. Acquir Immune Defic. Syndr.,1994
2. A mutation in helicase motif IV of herpes simplex virus type 1 UL5 that results in reduced growth in vitro and lower virulence in a murine infection model is related to the predicted helicase structure;Biswas;J. Gen. Virol.,2009
3. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections;Biswas;Future Med. Chem.,2014
4. Genital herpes complicating pregnancy;Brown;Obstet. Gynecol.,2005
5. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2;Chono;J. Antimicrob. Chemother.,2010
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The varicella-zoster virus ORF16 protein promotes both the nuclear transport and the protein abundance of the viral DNA polymerase subunit ORF28;Virus Research;2024-07
2. Interaction and assembly of the DNA replication core proteins of Kaposi’s sarcoma-associated herpesvirus;Microbiology Spectrum;2023-12-12
3. Amenamevir by Ugi-4CR;Green Chemistry;2023
4. A phase 3, randomized, double‐blind, placebo‐controlled study evaluating a single, patient‐initiated dose of amenamevir for recurrent herpes labialis;The Journal of Dermatology;2022-11-09
5. Single-Dose, Patient-Initiated Amenamevir Therapy for Recurrent Genital Herpes: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study;Open Forum Infectious Diseases;2022-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3